Content
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Article By:
Lorimer Wilson
Read
Monday, February 19, 2024 12:05 AM EDT
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex
Article By:
Lorimer Wilson
Read
Sunday, February 18, 2024 6:14 PM EDT
IXHL 's increase was based on the successful completion of an Investigational New Drug meeting with the FDA regarding the development of CannQuit-N for tobacco smoking cessation and relapse control.
As Expected, Cannabis MSOs Continue To Decline
Article By:
Lorimer Wilson
Read
Saturday, February 17, 2024 10:01 PM EDT
Last week I suggested that if the performance of the American Cannabis MSO Stocks Index (-7.1%) was any indication, then the hype in cannabis MSOs was over. That is indeed the case, as reflected by the further 6.6% decline this week.
Aurora Cannabis Q3 Financials Unimpressive: Stock Declines
Article By:
Lorimer Wilson
Read
Tuesday, February 13, 2024 4:18 PM EDT
Expects revenue increases, combined with continued cost controls and the acquisition of the remaining 90% of MedReleaf Australia, will be accretive to Adjusted EBITDA and accelerate its efforts to generate positive free cash flow this calendar year.
In this article: ACB
Q3 Financials Drive Canopy Growth Stock Down Further: Now -26% YTD
Article By:
Lorimer Wilson
Read
Monday, February 12, 2024 2:32 PM EDT
Q3 results demonstrate improved profitability and reduction in cash burn with the business delivering profitability improvements as well as sequential growth reinforcing their confidence in realizing a sustainable, profitable future.
In this article: CGC